Articles From: Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® to OTI Reports 2013 First Quarter Financial Results


2013/2/19
Osiris Therapeutics, Inc. (NASDAQ: OSIR) , the leading stem cell company developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that the European Medicines Agency (EMA) has designated Osiris as the Orphan Drug title holder for Prochymal® (remestemcel-L ). The EU Commission adopted the decision to transfer the designation of Prochymal (ex-vivo cultured adult human mesenchymal stem cells) as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council.
Sign-up for Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® investment picks
2013/3/6
Osiris Therapeutics, Inc. (NASDAQ: OSIR) the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the fourth quarter and full year ended December 31, 2012.
Sign-up for Osiris Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/2/18
Osiris Therapeutics, Inc. (NASDAQ: OSIR) , the leading company focused on developing and marketing stem cell products to treat serious medical conditions, announced today the successful conclusion of a patent challenge in Australia by an opponent whose identity under Australian law was not disclosed.
Sign-up for Osiris Therapeutics Successfully Defends Key Stem Cell Patent Challenge investment picks
2013/4/29
Osiris Therapeutics, Inc. (NASDAQ: OSIR) , the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C.
Sign-up for Osiris Therapeutics to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/3/14
Osiris Therapeutics, Inc. (NASDAQ: OSIR) , the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C.
Sign-up for Osiris Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference investment picks
2013/5/30
Osiris Therapeutics, Inc. (NASDAQ: OSIR) , the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C.
Sign-up for Osiris Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference investment picks
2013/4/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0867416001&sourceType=1 http://www.ccnmatthews.com/logos/20080630-Osisko_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Comments on Trading Activities investment picks
2013/2/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0852379001&sourceType=1 http://www.ccnmatthews.com/logos/20080630-Osisko_200.jpg http://www.marketwire.com/library/20130211-MPY_Award_300.jpg From left to right: Donald Leroux, CMP Chair; Denis Cimon, Vice-President, Technical Services and Jean Chateauneuf, Production Superintendent, Osisko Mining Corporation; and Erin Legault-Seguin, Past CMP Chair.
Sign-up for Osisko Mining Corporation: Denis Cimon Receives the 2013 Mineral Processor of the Year Award investment picks
2013/4/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0865569001&sourceType=1 http://www.ccnmatthews.com/logos/20080630-Osisko_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Previews Q1 2013 Canadian Malartic Operating Results investment picks
2013/5/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0872754001&sourceType=1 http://www.ccnmatthews.com/logos/20080630-Osisko_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Reports First Quarter 2013 Results investment picks
2013/5/17
Siemens AG's (SI) Osram aims to break even in fiscal 2013 and expects revenue at the previous year's level, the lighting unit said at its capital markets day Friday.
Sign-up for Osram Aims to Break Even in Fiscal 2013 investment picks
2013/4/9
SAN JOSE, April 9, 2013 /PRNewswire/ -- Echelon Corporation ( NASDAQ : ELON ) and OSRAM GmbH, a wholly-owned subsidiary of Siemens AG, and one of the leading light manufacturers in the world, today announced that OSRAM will offer a standards-based street lighting management system that incorporates control networking technology from Echelon corporation.
Sign-up for OSRAM Integrates Echelon Technology in Intelligent Street Lighting Solution investment picks
2013/5/8
Osram said Wednesday it will shut down its production site in Indonesia's Tangerang with some 1,100 employees as part of the savings program of Siemens' lighting unit which aims for a public listing.
Sign-up for Osram to Close Light Bulb Factory in Indonesia investment picks
2013/4/30
To Host Conference call at 9:00 am ET on April 30, 2013 SHANGHAI , April 30, 2013 /PRNewswire-FirstCall/ -- Ossen Innovation Co., Ltd.
Sign-up for Ossen Innovation Announces Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/2/25
SHANGHAI , Feb.
Sign-up for Ossen Innovation Appoints new CFO investment picks
2013/1/30
SHANGHAI , Jan.
Sign-up for Ossen Innovation Receives NASDAQ Notification of Non-Compliance with Minimum Bid Price Rule investment picks
2013/4/25
SHANGHAI , April 25, 2013 /PRNewswire-FirstCall/ -- Ossen Innovation Co., Ltd.
Sign-up for Ossen Innovation to Host Fourth Quarter 2012 Earnings Conference Call on Tuesday, April 30, 2013 at 9:00 am ET investment picks
2013/2/1
Otelco Inc. (NASDAQ: OTT) (TSX: OTT.un) , a wireline telecommunication services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia, today announced a restructuring transaction, which will strengthen the Company by deleveraging its balance sheet and reducing its overall indebtedness by approximately $135 million.
Sign-up for Otelco Announces Restructuring Transaction investment picks
2013/5/24
Otelco Inc. announced that it has emerged from bankruptcy and completed its balance sheet restructuring process, including an extension of its senior credit facility.
Sign-up for Otelco Emerges from Bankruptcy with New Credit Facility and New Listed Security investment picks
2013/5/7
Otelco Inc. (NASDAQ: OTT) , a wireline telecommunications services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia, today announced results for its first quarter ended March 31, 2013.
Sign-up for Otelco Reports First Quarter 2013 Results and Progress of Balance Sheet Restructuring investment picks
2013/5/7
Otelco Reports First Quarter 2013 Results and Progress of Balance Sheet Restructuring Canada NewsWire ONEONTA, AL, May 7, 2013 /CNW/ - Otelco Inc. (NASDAQ: OTT) , a wireline telecommunications services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia, today announced results for its first quarter ended March 31 , 2013.
Sign-up for Otelco Reports First Quarter 2013 Results and Progress of Balance Sheet Restructuring investment picks
2013/2/25
Otelco Reports Fourth Quarter and Year 2012 Results Canada NewsWire ONEONTA, AL, Feb.
Sign-up for Otelco Reports Fourth Quarter and Year 2012 Results investment picks
2013/2/25
Otelco Inc. (NASDAQ: OTT) (TSX: OTT.un) , a wireline telecommunications services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia, today announced results for its fourth quarter and year ended December 31, 2012.
Sign-up for Otelco Reports Fourth Quarter and Year 2012 Results investment picks
2013/3/25
Otelco Inc. (NASDAQ: OTT) (TSX: OTT.un) , a wireline telecommunication services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia, announced today that on March 24, 2013, the Company filed voluntary petitions for reorganization under chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
Sign-up for Otelco Takes Next Steps to Implement Restructuring investment picks
2013/3/25
Otelco takes next steps to implement restructuring Canada NewsWire ONEONTA, AL, March 25, 2013 /CNW/ - Otelco Inc. (NASDAQ: OTT) (TSX:  OTT.un) , a wireline telecommunication services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia, announced today that on March 24, 2013 , the Company filed voluntary petitions for reorganization under chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
Sign-up for Otelco takes next steps to implement restructuring investment picks
2013/1/29
Otelco to Release 2012 Fourth Quarter and Year-End Results Canada NewsWire ONEONTA, AL, Jan.
Sign-up for Otelco to Release 2012 Fourth Quarter and Year-End Results investment picks
2013/5/13
ROSH PINA, Israel, May 13, 2013 (GLOBE NEWSWIRE) -- On Track Innovations Ltd.
Sign-up for OTI Provides Update About Patent Infringement Suit Against T-Mobile investment picks
2013/5/20
Deliveries of All Units are Expected This Year ROSH PINA, Israel, May 20, 2013 (GLOBE NEWSWIRE) -- On Track Innovations Ltd.
Sign-up for OTI Receives an Order for 30,000 NFC and Contactless Payment Readers to be Deployed in North America for Use in the Retail Petroleum Market investment picks
2013/3/19
ROSH PINA, Israel, March 19, 2013 (GLOBE NEWSWIRE) -- On Track Innovations Ltd.
Sign-up for OTI Reports 2012 Year-End and Fourth Quarter Financial Results investment picks
2013/5/31
ROSH PINA, Israel, May 31, 2013 (GLOBE NEWSWIRE) -- On Track Innovations Ltd.
Sign-up for OTI Reports 2013 First Quarter Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® to OTI Reports 2013 First Quarter Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity